Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Advanced Fibrosis in Type 2 Diabetes Mellitus Patients. Pjmcr. 2026;5(1):163-174. doi:10.5281/zenodo.18345788